Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies
Epigallocatechin gallate (EGCG), a green tea catechin, has gained the attention of current
study due to its excellent health‐promoting effects. It possesses anti‐obesity, antimicrobial …
study due to its excellent health‐promoting effects. It possesses anti‐obesity, antimicrobial …
Evaluation of mesoporous silica nanoparticles for oral drug delivery–current status and perspective of MSNs drug carriers
J Florek, R Caillard, F Kleitz - Nanoscale, 2017 - pubs.rsc.org
The oral pathway is considered as the most common method for drug administration,
although many drugs, especially the highly pH-and/or enzymatic biodegradable peptide …
although many drugs, especially the highly pH-and/or enzymatic biodegradable peptide …
Nanomedicine for increasing the oral bioavailability of cancer treatments
Oral administration is an appealing route of delivering cancer treatments. However, the
gastrointestinal tract is characterized by specific and efficient physical, chemical, and …
gastrointestinal tract is characterized by specific and efficient physical, chemical, and …
Encapsulation and controlled release of resveratrol within functionalized mesoporous silica nanoparticles for prostate cancer therapy
Resveratrol (RES) is a naturally existing polyphenol which exhibits anti-oxidant, anti-
inflammatory, and anti-cancer properties. In recent years, RES has attracted attention for its …
inflammatory, and anti-cancer properties. In recent years, RES has attracted attention for its …
Mesoporous silica nanoparticles as delivery carriers: An overview of drug loading techniques
Mesoporous silica nanoparticles (MSNs) are arising as a promising delivery system for a
more effective and safer therapy of many diseases, such as cancer, osteoporosis and …
more effective and safer therapy of many diseases, such as cancer, osteoporosis and …
Recent advances in nanocarriers for nutrient delivery
For the past few years, there has been a surge in the use of nutraceuticals. The global
nutraceuticals market in 2020 was USD 417.66 billion, and the market value is expected to …
nutraceuticals market in 2020 was USD 417.66 billion, and the market value is expected to …
Efficient delivery of curcumin by alginate oligosaccharide coated aminated mesoporous silica nanoparticles and in vitro anticancer activity against colon cancer cells
C Liu, F Jiang, Z **ng, L Fan, Y Li, S Wang, J Ling… - Pharmaceutics, 2022 - mdpi.com
We designed and synthesized aminated mesoporous silica (MSN-NH2), and functionally
grafted alginate oligosaccharides (AOS) on its surface to get MSN-NH2-AOS nanoparticles …
grafted alginate oligosaccharides (AOS) on its surface to get MSN-NH2-AOS nanoparticles …
Silica-based systems for oral delivery of drugs, macromolecules and cells
R Diab, N Canilho, IA Pavel, FB Haffner… - Advances in Colloid and …, 2017 - Elsevier
According to the US Food and Drug Administration and the European Food Safety Authority,
amorphous forms of silica and silicates are generally recognized to be safe as oral delivery …
amorphous forms of silica and silicates are generally recognized to be safe as oral delivery …
Size-controlled functionalized mesoporous silica nanoparticles for tunable drug release and enhanced anti-tumoral activity
M Bouchoucha, MF Cote, R C.-Gaudreault… - Chemistry of …, 2016 - ACS Publications
Mesoporous silica nanoparticles (MSNs) are considered as one of the most promising
nanovectors for controlled drug delivery. For the design of ideal drug nanocarriers, several …
nanovectors for controlled drug delivery. For the design of ideal drug nanocarriers, several …
The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential
I Robertson, TW Hau, F Sami, MS Ali… - International Journal of …, 2022 - Elsevier
Chemopreventive properties of resveratrol has been studied for decades. Despite its
potential for chemotherapeutic advancement, the compound has pharmaceutical limitations …
potential for chemotherapeutic advancement, the compound has pharmaceutical limitations …